122 related articles for article (PubMed ID: 23047828)
1. Circulating very-low-density lipoprotein from subjects with impaired glucose tolerance accelerates adrenocortical cortisol and aldosterone synthesis.
Saha S; Schwarz PE; Bergmann S; Bornstein SR; Graessler J; Kopprasch S
Horm Metab Res; 2013 Feb; 45(2):169-72. PubMed ID: 23047828
[TBL] [Abstract][Full Text] [Related]
2. Prediabetic and diabetic in vivo modification of circulating low-density lipoprotein attenuates its stimulatory effect on adrenal aldosterone and cortisol secretion.
Kopprasch S; Pietzsch J; Ansurudeen I; Graessler J; Krug AW; Ehrhart-Bornstein M; Bornstein SR
J Endocrinol; 2009 Jan; 200(1):45-52. PubMed ID: 18835979
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk Between Glycoxidative Modification of Low-Density Lipoprotein, Angiotensin II-Sensitization, and Adrenocortical Aldosterone Release.
Saha S; Bornstein SR; Graessler J; Kopprasch S
Horm Metab Res; 2015 Oct; 47(11):855-60. PubMed ID: 25602349
[TBL] [Abstract][Full Text] [Related]
4. Very-low-density lipoprotein mediates transcriptional regulation of aldosterone synthase in human adrenocortical cells through multiple signaling pathways.
Saha S; Bornstein SR; Graessler J; Kopprasch S
Cell Tissue Res; 2012 Apr; 348(1):71-80. PubMed ID: 22331364
[TBL] [Abstract][Full Text] [Related]
5. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
[TBL] [Abstract][Full Text] [Related]
6. Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity.
Marini MA; Fiorentino TV; Andreozzi F; Mannino GC; Perticone M; Sciacqua A; Perticone F; Sesti G
Acta Diabetol; 2017 Aug; 54(8):775-784. PubMed ID: 28577138
[TBL] [Abstract][Full Text] [Related]
7. Diabetic lipoproteins and adrenal aldosterone synthesis--a possible pathophysiological link?
Saha S; Willenberg HS; Bornstein SR; Graessler J; Kopprasch S
Horm Metab Res; 2012 Mar; 44(3):239-44. PubMed ID: 22147656
[TBL] [Abstract][Full Text] [Related]
8. Modified high-density lipoprotein modulates aldosterone release through scavenger receptors via extra cellular signal-regulated kinase and Janus kinase-dependent pathways.
Saha S; Graessler J; Schwarz PE; Goettsch C; Bornstein SR; Kopprasch S
Mol Cell Biochem; 2012 Jul; 366(1-2):1-10. PubMed ID: 22382638
[TBL] [Abstract][Full Text] [Related]
9. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
[TBL] [Abstract][Full Text] [Related]
10. Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study.
Lorenzo C; Hartnett S; Hanley AJ; Rewers MJ; Wagenknecht LE; Karter AJ; Haffner SM
J Clin Endocrinol Metab; 2013 Apr; 98(4):1622-30. PubMed ID: 23450048
[TBL] [Abstract][Full Text] [Related]
11. Adrenal cell aldosterone production is stimulated by very-low-density lipoprotein (VLDL).
Xing Y; Rainey WE; Apolzan JW; Francone OL; Harris RB; Bollag WB
Endocrinology; 2012 Feb; 153(2):721-31. PubMed ID: 22186415
[TBL] [Abstract][Full Text] [Related]
12. Impaired glucose tolerance is not associated with lipid intolerance.
Henkel E; Temelkova-Kurktschiev T; Koehler C; Pietzsch J; Leonhardt W; Hanefeld M
Diabetes Nutr Metab; 2002 Apr; 15(2):84-90. PubMed ID: 12059096
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and beta-cell dysfunction in people with prediabetes according to criteria based on glycemia and glycosylated hemoglobin.
Tura A; Göbl C; Moro E; Pacini G
Endocr J; 2017 Jan; 64(1):117-122. PubMed ID: 27628439
[TBL] [Abstract][Full Text] [Related]
14. Postprandial lipaemia in patients with impaired fasting glucose, impaired glucose tolerance and diabetes mellitus.
Madhu SV; Kant S; Srivastava S; Kant R; Sharma SB; Bhadoria DP
Diabetes Res Clin Pract; 2008 Jun; 80(3):380-5. PubMed ID: 18321605
[TBL] [Abstract][Full Text] [Related]
15. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.
Faerch K; Vaag A; Holst JJ; Glümer C; Pedersen O; Borch-Johnsen K
Diabetologia; 2008 May; 51(5):853-61. PubMed ID: 18317726
[TBL] [Abstract][Full Text] [Related]
16. Impaired β-cell function and decreased insulin sensitivity in subjects with normal oral glucose tolerance but isolated high glycosylated hemoglobin.
Fu Q; Sun M; Wang Z; He W; Duan Y; Yang T
Endocr J; 2018 Jan; 65(1):13-22. PubMed ID: 28904260
[TBL] [Abstract][Full Text] [Related]
17. VLDL-activated cell signaling pathways that stimulate adrenal cell aldosterone production.
Tsai YY; Rainey WE; Johnson MH; Bollag WB
Mol Cell Endocrinol; 2016 Sep; 433():138-46. PubMed ID: 27222295
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of bufalin and cinobufagin on steroidogenesis via the activation of ERK in human adrenocortical cells.
Kau MM; Wang JR; Tsai SC; Yu CH; Wang PS
Br J Pharmacol; 2012 Mar; 165(6):1868-1876. PubMed ID: 21913902
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men.
Wang J; Stančáková A; Soininen P; Kangas AJ; Paananen J; Kuusisto J; Ala-Korpela M; Laakso M
J Intern Med; 2012 Dec; 272(6):562-72. PubMed ID: 22650159
[TBL] [Abstract][Full Text] [Related]
20. Effects of Adipocyte-derived Factors on the Adrenal Cortex.
Shimada H; Noro E; Suzuki S; Sakamoto J; Sato I; Parvin R; Yokoyama A; Sugawara A
Curr Mol Pharmacol; 2020; 13(1):2-6. PubMed ID: 31613736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
